The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ERIC 2018 | Current ERIC research in the CLL genomics field
The European Research Initiative on Chronic Lymphocytic Leukemia (ERIC) supports large-scale collaborations across multiple centres to characterize relevant mutations in chronic lymphocytic leukemia (CLL). Here, Richard Rosenquist, MD, PhD, of the Karolinska University Hospital, Solna, Sweden, discusses these efforts and explores future steps, such as identifying the frequency, co-occurrence and prognostic value of genetic aberrations. This interview took place at the ERIC International Meeting 2018, held in Barcelona, Spain.
